Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer (Q46830735)
Jump to navigation
Jump to search
scientific article published on 4 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer |
scientific article published on 4 March 2013 |
Statements
1 reference
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer (English)
1 reference
1 reference
Grace O'Callaghan
1 reference
Aideen Ryan
1 reference
Peter Neary
1 reference
Caitlin O'Mahony
1 reference
Aileen Houston
1 reference
4 March 2013
1 reference
133
1 reference
4
1 reference
825-834
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference